Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network

被引：0

作者：

Rose, Angela M. C. ^{[1
]}

Pozo, Francisco ^{[2
,3
]}

Martinez-Baz, Ivan ^{[3
,4
]}

Mazagatos, Clara ^{[3
,5
]}

Bossuyt, Nathalie ^{[6
]}

Cauchi, John Paul ^{[7
]}

Petrovic, Goranka ^{[8
]}

Loghin, Isabela I. ^{[9
]}

Vaikutyte, Roberta ^{[10
]}

Buda, Silke ^{[11
]}

Machado, Ausenda ^{[12
]}

Duffy, Roisin ^{[13
]}

Oroszi, Beatrix ^{[14
]}

Howard, Jennifer ^{[1
]}

Echeverria, Aitziber ^{[3
,4
]}

Andreu, Cristina ^{[15
]}

Barbezange, Cyril ^{[6
]}

Dziugyte, Ausra ^{[7
]}

Nonkovic, Diana ^{[16
]}

Popescu, Corneliu-Petru ^{[17
]}

Majauskaite, Fausta ^{[18
]}

Tolksdorf, Kristin ^{[11
]}

Gomez, Veronica ^{[12
]}

Domegan, Lisa ^{[13
]}

Horvath, Judit Krisztina ^{[14
]}

Castilla, Jesus ^{[3
,4
]}

Garcia, Miriam ^{[19
]}

Demuyser, Thomas ^{[20
]}

Borg, Maria-Louise ^{[7
]}

Tabain, Irena ^{[8
]}

Lazar, Mihaela ^{[21
]}

Kubiliute, Ieva ^{[18
]}

Duerrwald, Ralf ^{[11
]}

Guiomar, Raquel ^{[12
]}

O'Donnell, Joan ^{[13
]}

Kristof, Katalin ^{[14
]}

Nicolay, Nathalie ^{[22
]}

Bacci, Sabrina ^{[22
]}

Kissling, Esther ^{[1
]}

机构：

[1] Epiconcept, Paris, France

[2] Inst Hlth Carlos III, Natl Ctr Microbiol, Madrid, Spain

[3] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain

[4] Inst Salud Publ Navarra IdiSNA, Pamplona, Spain

[5] Inst Hlth Carlos III, Natl Ctr Epidemiol, Madrid, Spain

[6] Sciensano, Brussels, Belgium

[7] Dept Hlth Regulat Hlth Promot & Dis Prevent, Msida, Malta

[8] Croatian Inst Publ Hlth, Zagreb, Croatia

[9] St Parascheva Clin Hosp Infect Dis, Iasi, Romania

[10] Lithuanian Univ Hlth Sci, Kaunas, Lithuania

[11] Robert Koch Inst, Berlin, Germany

[12] Natl Inst Hlth Dr Ricardo Jorge, Lisbon, Portugal

[13] Hlth Serv Execut Hlth Protect Surveillance Ctr, Dublin, Ireland

[14] Semmelweis Univ, Budapest, Hungary

[15] Serv Extremeno Salud, Subdirecc Epidemiol, Direcc Gen Salud Publ, Merida, Spain

[16] Teaching Publ Hlth Inst Split Dalmatia Cty, Split, Croatia

[17] Dr Victor Babes Clin Hosp Infect & Trop Dis, Bucharest, Romania

[18] Vilnius Univ, Inst Clin Med, Med Fac, Vilnius, Lithuania

[19] Dept San, Dept Sanidad, Gobierno Aragon, Zaragoza, Spain

[20] Dept Microbiol & Infect control, Dept Microbiol & Infect Control, Brussels, Belgium

[21] Cantacuzino Natl Mil Med Inst Res & Dev, Bucharest, Romania

[22] European Ctr Dis Prevent & Control, Stockholm, Sweden

来源：

INFLUENZA AND OTHER RESPIRATORY VIRUSES | 2024年 / 18卷 / 02期

关键词：

hospital; influenza; SARI patients; test-negative design; vaccine effectiveness;

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We conducted a multicentre hospital-based test-negative case-control study to measure vaccine effectiveness (VE) against PCR-confirmed influenza in adult patients with severe acute respiratory infection (SARI) during the 2022/2023 influenza season in Europe. Among 5547 SARI patients >= 18 years, 2963 (53%) were vaccinated against influenza. Overall VE against influenza A(H1N1)pdm09 was 11% (95% CI: -23-36); 20% (95% CI: -4-39) against A(H3N2) and 56% (95% CI: 22-75) against B. During the 2022/2023 season, while VE against hospitalisation with influenza B was >55%, it was <= 20% for influenza A subtypes. While influenza vaccination should be a priority for future seasons, improved vaccines against influenza are needed.

引用

页数：9

共 50 条

[21] Distribution of A(H1N1)pdm09 Influenza Vaccine: Need for Greater Consideration of Smaller Jails [J].

Lee, Alice S. ;

Berendes, David M. ;

Seib, Katherine ;

Whitney, Ellen A. S. ;

Chavez, R. Scott ;

Meyer, Patricia Lynn ;

Berkelman, Ruth L. ;

Omer, Saad B. ;

Spaulding, Anne C. .

JOURNAL OF CORRECTIONAL HEALTH CARE, 2014, 20 (03) :228-239

[22] Co-circulation of influenza A(H1N1), A(H3N2), B(Yamagata) and B(Victoria) during the 2017-2018 influenza season in Zhejiang Province, China [J].

Mao, Haiyan ;

Sun, Yi ;

Chen, Yin ;

Lou, Xiuyu ;

Yu, Zhao ;

Wang, Xinying ;

Ding, Zheyuan ;

Cheng, Wei ;

Zhang, Dan ;

Zhang, Yanjun ;

Jiang, Jianmin .

EPIDEMIOLOGY AND INFECTION, 2020, 148

[23] A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults [J].

Ortiz, Justin R. ;

Bernstein, David, I ;

Hoft, Daniel F. ;

Woods, Christopher W. ;

McClain, Micah T. ;

Frey, Sharon E. ;

Brady, Rebecca C. ;

Bryant, Christopher ;

Wegel, Ashley ;

Frenck Jr, Robert W. ;

Walter, Emmanuel B. ;

Abate, Getahun ;

Williams, Sarah R. ;

Atmar, Robert L. ;

Keitel, Wendy A. ;

Rouphael, Nadine ;

Memoli, Mathew J. ;

Makhene, Mamodikoe K. ;

Roberts, Paul C. ;

Neuzil, Kathleen M. .

JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (03) :287-298

[24] Influenza virus A(H1N1)pdm09 hemagglutinin polymorphism and associated disease in southern Germany during the 2010/11 influenza season [J].

Valeria Falcone ;

Sibylle Bierbaum ;

Winfried Kern ;

Udo Kontny ;

Hartmut Bertz ;

Daniela Huzly ;

Marcus Panning .

Archives of Virology, 2013, 158 :1297-1303

[25] Mid-Term Estimates of Influenza Vaccine Effectiveness against the A(H1N1)pdm09 Prevalent Circulating Subtype in the 2023/24 Season: Data from the Sicilian RespiVirNet Surveillance System [J].

Costantino, Claudio ;

Mazzucco, Walter ;

Graziano, Giorgio ;

Maida, Carmelo Massimo ;

Vitale, Francesco ;

Tramuto, Fabio .

VACCINES, 2024, 12 (03)

[26] Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season [J].

Price, Ashley M. ;

Flannery, Brendan ;

Talbot, H. Keipp ;

Grijalva, Carlos G. ;

Wernli, Karen J. ;

Phillips, C. Hallie ;

Monto, Arnold S. ;

Martin, Emily T. ;

Belongia, Edward A. ;

McLean, Huong Q. ;

Gaglani, Manjusha ;

Mutnal, Manohar ;

Geffel, Krissy Moehling ;

Nowalk, Mary Patricia ;

Tartof, Sara Y. ;

Florea, Ana ;

McLean, Callie ;

Kim, Sara S. ;

Patel, Manish M. ;

Chung, Jessie R. .

CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) :1358-1363

[27] Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe [J].

Broberg, E. ;

Melidou, A. ;

Prosenc, K. ;

Bragstad, K. ;

Hungnes, O. .

EUROSURVEILLANCE, 2016, 21 (13) :8-21

[28] ANTIVIRAL EFFECT OF ⟪KAGOCEL⟫ SUBSTANCE IN VITRO ON INFLUENZA VIRUSES H1N1, H1N1pdm09 AND H3N2 [J].

Fediakina, I. T. ;

Konopleva, M., V ;

Proshina, E. S. ;

Linnik, E., V ;

Nikitina, N., I .

VOPROSY VIRUSOLOGII, 2019, 64 (03) :125-131

[29] Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients [J].

Ohfuji, Satoko ;

Fukushima, Wakaba ;

Sasaki, Yachiyo ;

Tamori, Akihiro ;

Kurai, Osamu ;

Kioka, Kiyohide ;

Maeda, Kazuhiro ;

Maeda, Akiko ;

Hirota, Yoshio .

LIVER INTERNATIONAL, 2014, 34 (05) :700-706

[30] WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011 [J].

Klimov, Alexander I. ;

Garten, Rebecca ;

Russell, Colin ;

Barr, Ian G. ;

Besselaar, Terry G. ;

Daniels, Rod ;

Engelhardt, Othmar G. ;

Grohmann, Gary ;

Itamura, Shigeyuki ;

Kelso, Anne ;

McCauley, John ;

Odagiri, Takato ;

Smith, Derek ;

Tashiro, Masato ;

Xu, Xiyan ;

Webby, Richard ;

Wang, Dayan ;

Ye, Zhiping ;

Shu Yuelong ;

Zhang, Wenqing ;

Cox, Nancy .

VACCINE, 2012, 30 (45) :6461-6471

← 1 2 3 4 5 →